Moving Forward in HIV Vaccine Development

被引：20

作者：

Letvin, Norman L. ^{[1
]}

机构：

[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA

来源：

SCIENCE | 2009年 / 326卷 / 5957期

关键词：

D O I：

10.1126/science.1183278

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1196 / 1198

页数：3

共 8 条

[1]

Belshe R, 2004, SCIENCE, V305, P177

[2] Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].

Buchbinder, Susan P. ;

Mehrotra, Devon V. ;

Duerr, Ann ;

Fitzgerald, Daniel W. ;

Mogg, Robin ;

Li, David ;

Gilbert, Peter B. ;

Lama, Javier R. ;

Marmor, Michael ;

del Rio, Carlos ;

McElrath, M. Juliana ;

Casimiro, Danilo R. ;

Gottesdiener, Keith M. ;

Chodakewitz, Jeffrey A. ;

Corey, Lawrence ;

Robertson, Michael N. .

LANCET, 2008, 372 (9653) :1881-1893

[3] Public health - A sound rationale needed for phase IIIHIV-1 vaccine trials [J].

Burton, DR ;

Desrosiers, RC ;

Doms, RW ;

Feinberg, MB ;

Gallo, RC ;

Hahn, B ;

Hoxie, JA ;

Hunter, E ;

Korber, B ;

Landay, A ;

Lederman, MM ;

Lieberman, J ;

McCune, JM ;

Moore, JP ;

Nathanson, N ;

Picker, L ;

Richman, D ;

Rinaldo, C ;

Stevenson, M ;

Watkins, DI ;

Wolinsky, SM ;

Zack, JA .

SCIENCE, 2004, 303 (5656) :316-316

[4]

Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404

[5] Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1 [J].

Mascola, JR ;

Snyder, SW ;

Weislow, OS ;

Belay, SM ;

Belshe, RB ;

Schwartz, DH ;

Clements, ML ;

Dolin, R ;

Graham, BS ;

Gorse, GJ ;

Keefer, MC ;

McElrath, MJ ;

Walker, MC ;

Wagner, KF ;

McNeil, JG ;

McCutchan, FE ;

Burke, DS .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :340-348

[6]

MICHAEL N, COMMUNICATION

[7] Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand [J].

Rerks-Ngarm, Supachai ;

Pitisuttithum, Punnee ;

Nitayaphan, Sorachai ;

Kaewkungwal, Jaranit ;

Chiu, Joseph ;

Paris, Robert ;

Premsri, Nakorn ;

Namwat, Chawetsan ;

de Souza, Mark ;

Adams, Elizabeth ;

Benenson, Michael ;

Gurunathan, Sanjay ;

Tartaglia, Jim ;

McNeil, John G. ;

Francis, Donald P. ;

Stablein, Donald ;

Birx, Deborah L. ;

Chunsuttiwat, Supamit ;

Khamboonruang, Chirasak ;

Thongcharoen, Prasert ;

Robb, Merlin L. ;

Michael, Nelson L. ;

Kunasol, Prayura ;

Kim, Jerome H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (23) :2209-2220

[8] Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120 - Negative results fail to trigger a phase 3 correlates trial [J].

Russell, Nina D. ;

Graham, Barney S. ;

Keefer, Michael C. ;

McElrath, M. Juliana ;

Self, Steve G. ;

Weinhold, Kent J. ;

Montefiroi, David C. ;

Ferrari, Guido ;

Horton, Helen ;

Tomaras, Georgia D. ;

Gurunathan, Sanjay ;

Baglyos, Lynn ;

Frey, Sharon E. ;

Mulligan, Mark J. ;

Harro, Clayton D. ;

Buchbinder, Susan P. ;

Baden, Lindsey R. ;

Blattner, William A. ;

Koblin, Beryl A. ;

Corey, Lawrence .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (02) :203-212

← 1 →